Veradermics reported positive Phase 3 trial results for its oral hair growth drug, VDPHL01, potentially becoming the first FDA-approved non-hormonal pill for male pattern baldness.
Veradermics reported positive Phase 3 trial results for its oral hair growth drug, VDPHL01, potentially becoming the first FDA-approved non-hormonal pill for male pattern baldness.